We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$251M
AUM Growth
+$108M
Cap. Flow
+$110M
Cap. Flow %
43.64%
Top 10 Hldgs %
8.26%
Holding
678
New
364
Increased
61
Reduced
41
Closed
212

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$2.14M
2
BAX icon
Baxter International
BAX
+$2.05M
3
CVX icon
Chevron
CVX
+$2.05M
4
EA icon
Electronic Arts
EA
+$1.96M
5
LI icon
Li Auto
LI
+$1.85M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.53M
2
V icon
Visa
V
+$1.46M
3
SNPS icon
Synopsys
SNPS
+$1.41M
4
LOW icon
Lowe's Companies
LOW
+$1.41M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 19.53%
2 Consumer Discretionary 17.33%
3 Healthcare 14.26%
4 Financials 12.38%
5 Industrials 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPS
426
DELISTED
Altus Power
AMPS
$157K 0.06%
+28,600
New +$201K
UMC icon
427
United Microelectronic
UMC
$46.9B
$154K 0.06%
+17,600
New +$143K
VLY icon
428
Valley National Bancorp
VLY
$8.02B
$144K 0.06%
+15,600
New +$173K
EB
429
DELISTED
Eventbrite
EB
$142K 0.06%
+16,599
New +$137K
BRY
430
DELISTED
Berry Corp
BRY
$141K 0.06%
17,930
+6,847
+62% +$59.4K
VOD icon
431
Vodafone
VOD
$35.9B
$139K 0.06%
+12,556
New +$143K
INFN
432
DELISTED
Infinera Corporation Common Stock
INFN
$137K 0.05%
+17,700
New +$129K
OCUL icon
433
Ocular Therapeutix
OCUL
$1.84B
$137K 0.05%
+25,972
New +$123K
TVRD
434
Tvardi Therapeutics
TVRD
$19M
$136K 0.05%
+771
New +$258K
ADT icon
435
ADT
ADT
$5.76B
$129K 0.05%
+17,830
New +$145K
NMRK icon
436
Newmark Group
NMRK
$2.72B
$122K 0.05%
17,200
-161
-0.9% -$1.29K
DNOW icon
437
DNOW Inc
DNOW
$2.6B
$117K 0.05%
+10,500
New +$131K
UA icon
438
Under Armour Class C
UA
$2.83B
$113K 0.05%
+13,300
New +$122K
BW icon
439
Babcock & Wilcox
BW
$1.42B
$110K 0.04%
+18,092
New +$112K
CHS
440
DELISTED
Chicos FAS, Inc.
CHS
$109K 0.04%
+19,870
New +$106K
CHRS icon
441
Coherus Oncology
CHRS
$222M
$106K 0.04%
+15,465
New +$120K
LXU icon
442
LSB Industries
LXU
$707M
$105K 0.04%
+10,140
New +$124K
EVGO icon
443
EVgo
EVGO
$227M
$104K 0.04%
+13,300
New +$78.2K
RXRX icon
444
Recursion Pharmaceuticals
RXRX
$1.69B
$103K 0.04%
+15,374
New +$122K
HOUS
445
DELISTED
Anywhere Real Estate
HOUS
$102K 0.04%
19,254
-12,141
-39% -$82.7K
NVAX icon
446
Novavax
NVAX
$1.22B
$96.9K 0.04%
+13,986
New +$129K
VERI icon
447
Veritone
VERI
$103M
$96.7K 0.04%
+16,580
New +$114K
ALHC icon
448
Alignment Healthcare
ALHC
$3.02B
$96.6K 0.04%
+15,182
New +$145K
OIS icon
449
Oil States International
OIS
$497M
$95.2K 0.04%
+11,425
New +$96.9K
LPRO
450
DELISTED
Open Lending Corp
LPRO
$93.6K 0.04%
+13,297
New +$104K

Similar funds

AXQ Capital's Q1 2023 Portfolio in Review

As of Q1 2023, AXQ Capital held 678 positions worth $251M, up 75% from $144M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

AXQ Capital deployed $110M of net new capital in Q1 2023, opening 364 new positions and adding to 61 existing holdings. Its largest new stake was Baxter International: 48,314 shares worth $1.96M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.27M trimmed.

  • AXQ Capital's largest Q1 2023 buy was Baxter International: 48,314 shares worth $1.96M.
  • AXQ Capital added most to Home Depot in Q1 2023, an estimated $2.14M increase.
  • AXQ Capital's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.27M.
  • AXQ Capital fully exited Nike in Q1 2023, selling an estimated $1.53M.
  • AXQ Capital's ten largest holdings make up 8.3% of its $251M portfolio in Q1 2023.
  • AXQ Capital opened 364 new positions and closed 212 in Q1 2023.
  • AXQ Capital's portfolio value rose 75% quarter-over-quarter to $251M.

Based on AXQ Capital's 13F filing for Q1 2023, filed 10 May 2023.